AXGN

#4287
Axogen, Inc. - Common Stock
0.3 9 USD
-99.02%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.39
0.39
Faixa anual
0.39
45.75
Mudança diária
-99.02%
Mudança mensal
-99.07%
Mudança em 6 meses
-98.64%
Mudança anual
-97.84%
Fechamento anterior
40.4 2
Open
0.3 9
Mínimo
0.3 9
High
0.3 9
Volume
121
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

Axogen, Inc. - Common Stock

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator. As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use.

Notícias